0001209191-15-007510.txt : 20150129
0001209191-15-007510.hdr.sgml : 20150129
20150129173455
ACCESSION NUMBER: 0001209191-15-007510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150127
FILED AS OF DATE: 20150129
DATE AS OF CHANGE: 20150129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Machado Clarence Patrick
CENTRAL INDEX KEY: 0001311210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 15560094
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, 3RD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-27
0
0001011835
MEDIVATION, INC.
MDVN
0001311210
Machado Clarence Patrick
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2015-01-27
4
M
0
7294
10.585
A
38794
D
Common Stock
2015-01-27
4
M
0
28706
9.385
A
67500
D
Common Stock
2015-01-27
4
S
0
17200
104.93
D
50300
D
Common Stock
2015-01-27
4
S
0
18800
105.67
D
31500
D
Stock Option (Right to Buy)
10.585
2015-01-27
4
M
0
7294
0.00
D
2017-09-30
Common Stock
7294
0
D
Stock Option (Right to Buy)
9.385
2015-01-27
4
M
0
28706
0.00
D
2018-10-30
Common Stock
28706
107990
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices between $104.375 and $105.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $105.38 and $106.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Jennifer Rhodes, Attorney-in-fact
2015-01-28